Predictive value of lymphocyte immunophenotyping (LIP) in primary central nervous system lymphoma (PCNSL).

Authors

null

Axel Berthelot

APHM, Marseille, France

Axel Berthelot , Celine Boucard , Gregorio Petrirena , Chantal Campello , Olivier L. Chinot , Emeline Tabouret

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Primary CNS Tumors–Non-Glioma

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2063)

DOI

10.1200/JCO.2021.39.15_suppl.2063

Abstract #

2063

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2014 ASCO Annual Meeting

Lenalidomide in the treatment of relapsed primary central nervous system lymphoma (PCNSL).

Lenalidomide in the treatment of relapsed primary central nervous system lymphoma (PCNSL).

First Author: Caroline Houillier

First Author: Matthias Holdhoff

First Author: Feili Chen